That sounds like JCR with Temcell for aGVHD. JCR last month began expanding from 20 out to 200 hospitals with Temcell in Japan. Made it happen, probably learned from it too.
More cash should begin to come in from that one.
And while working on a larger market, trials and other partnering. Some things don't work out the way you need it to every time. Maybe the net needs to cast wider, like at the conference later in November.
Back pain stem cell injection, page-59
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |